SEVEN EIGHT CAPITAL, LP – Halozyme Therapeutics, Inc. Transaction History
SEVEN EIGHT CAPITAL, LP portfolio value:
$1.08M
portfolio value
SEVEN EIGHT CAPITAL, LP quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +112.25% | 14.52K shares | 517K | $39.54 | 27.45K |
| Q2 2022 | share | Increase | 0.00% | 12.93K shares | 569K | $44 | 12.93K |
| Q4 2021 | share | Decrease | -100.00% | -15.56K shares | -633K | $40.32 | 0 |
| Q3 2021 | share | Increase | 0.00% | 15.56K shares | 633K | $40.68 | 15.56K |
| Q2 2021 | share | Decrease | -100.00% | -4.73K shares | -202K | $45.41 | 0 |
| Q1 2021 | share | 0.00% | 0 shares | 0 | $41.69 | 4.73K | |
| Q4 2020 | share | Decrease | -60.96% | -7.4K shares | -117K | $42.71 | 4.73K |
| Q3 2020 | share | Increase | +48.11% | 3.94K shares | 99K | $26.28 | 12.13K |
| Q2 2020 | share | Increase | 0.00% | 8.19K shares | 220K | $26.81 | 8.19K |